A Polyamine-Centric, Blood-Based Metabolite Panel Predictive of Poor Response to CAR-T Cell Therapy in Large B Cell Lymphoma

Investigators tested whether an MYC-driven polyamine signature, as a liquid biopsy, is predictive of response to anti-CD19 CAR-T therapy in patients withrelapsed or refractory large B cell lymphoma.
[Cell Reports Medicine]
Full Article

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News